Cassava Sciences (NASDAQ:SAVA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.63M
Day Range	- - -
52 Wk Range	8.79 - 42.20
Market Cap	$1.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	41.19%
Days to Cover	16.8

Recent News

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?

GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on:

Erica Kollmann

Analysts Believe Cassava Sciences Now Has 300% Upside From Here

Cassava Sciences Inc. (NASDAQ:SAVA) is a biotech developing treatments for Alzheimer's disease. The company has a lot of controversy over its lead drug, simufilam, which attempts to go further than alleviate symptoms

MarketBeat

Analysts Believe Cassava Sciences Now Has 300% Upside From Here

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.63M
Day Range	- - -
52 Wk Range	8.79 - 42.20
Market Cap	$1.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	41.19%
Days to Cover	16.8

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cassava Sciences (SAVA) stock?

You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.

View our list of the best stock brokerages

Who are Cassava Sciences (SAVA) competitors?

Other companies in Cassava Sciences’s space includes: WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).

What is the forecast, or price target, for Cassava Sciences (SAVA) stock?

Cassava Sciences has a consensus price target of $89.00.

What is the current price for Cassava Sciences (SAVA)?

The stock price for Cassava Sciences (NASDAQ: SAVA) is $26.51 last updated November 20, 2024 at 7:59 PM EST.

Does Cassava Sciences (SAVA) pay a dividend?

A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

Cassava Sciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Cassava Sciences (SAVA) going to split?

There is no upcoming split for Cassava Sciences.

What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Cassava Sciences

Cassava Sciences (SAVA) Forecast